Drug Shortage Report for M-RANITIDINE

Last updated on 2020-09-17 History
Report ID 108895
Drug Identification Number 02473542
Brand name M-RANITIDINE
Common or Proper name Ranitidine
Company Name MANTRA PHARMA INC
Market Status MARKETED
Active Ingredient(s) RANITIDINE
Strength(s) 300MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100
ATC code A02BA
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2019-09-13
Estimated end date Unknown
Actual end date 2020-09-14
Shortage status Resolved
Updated date 2020-09-17
Company comments
Health Canada comments
Contact Address 9150, BOUL. LEDUC, SUITE 201
BROSSARD, QUEBEC
CANADA J4Y 0E3
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v13 2020-09-17 French Compare
v12 2020-09-17 English Compare
v11 2020-09-17 English Compare
v10 2020-09-17 French Compare
v9 2020-09-17 English Compare
v8 2020-09-17 French Compare
v7 2020-09-17 English Compare
v6 2020-09-17 French Compare
v5 2020-09-17 English Compare
v4 2020-09-17 French Compare
v3 2020-09-17 English Compare
v2 2020-03-18 French Compare
v1 2020-03-18 English Compare